000866620 001__ 866620
000866620 005__ 20210130003543.0
000866620 020__ $$a978-3-11-060156-5
000866620 037__ $$aFZJ-2019-05699
000866620 041__ $$aEnglish
000866620 1001_ $$0P:(DE-Juel1)131840$$aQaim, Syed M.$$b0$$eCorresponding author$$ufzj
000866620 245__ $$aMedical Radionuclide Production, Science and Technology
000866620 260__ $$aBerlin, Boston$$bDe Gruyter$$c2020
000866620 300__ $$a270 p.
000866620 3367_ $$2BibTeX$$aBOOK
000866620 3367_ $$0PUB:(DE-HGF)3$$2PUB:(DE-HGF)$$aBook$$bbook$$mbook$$s1575372909_14689
000866620 3367_ $$2DataCite$$aOutput Types/Book
000866620 3367_ $$2ORCID$$aBOOK
000866620 3367_ $$01$$2EndNote$$aBook
000866620 3367_ $$2DRIVER$$abook
000866620 520__ $$aThe work describes the production technology of standard medical radionuclides using reactors and cyclotrons for patient diagnosis and therapy. A special focus lies on the science and technology involved in the development of novel radionuclides for positron emission tomography (PET) and internal targeted radiotherapy. The availability of those radionuclides is opening up new potential in clinical research, especially in neurology, cardiology and oncology. The future perspectives of the developing technology are also discussed.
000866620 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000866620 588__ $$aDataset connected to CrossRef Book
000866620 909CO $$ooai:juser.fz-juelich.de:866620$$pVDB
000866620 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131840$$aForschungszentrum Jülich$$b0$$kFZJ
000866620 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000866620 9141_ $$y2020
000866620 920__ $$lyes
000866620 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000866620 980__ $$abook
000866620 980__ $$aVDB
000866620 980__ $$aI:(DE-Juel1)INM-5-20090406
000866620 980__ $$aUNRESTRICTED